Willis Towers Watson Public Limited Company WLTW has efficiently met the evolving demands and expectations of its clientele over time, creating a solid service portfolio in the process. Maintaining this impressive track record, this Zacks Rank #3 (Hold) insurance broker continues to deliver consistently only to emerge with more flying colors on the road ahead. […]
Nutanix Inc. NTNX is set to report fourth-quarter fiscal 2017 results on Aug 31. With this, the company will also report its first full fiscal year since it went public on Sep 30, 2016. […]
Cigna Corporation ( CI ) has been assigned the provisional shelf rating of (P)Baa1 by Moody’s Investors Service, a wing of Moody’s Corporation MCO . Concurrently, the rating agency assigned (P) Baa2 to provisional subordinated shelf and provisional junior subordinated shelf, and (P) Baa1 to provisional senior unsecured shelf. […]
Biogen Inc. BIIB announced data from a long-term study on its Alzheimer's disease (AD) candidate, aducanumab. Data from the study showed a continued benefit in the rate of amyloid decline over a two/three year period in patients with prodromal or mild Alzheimer’s disease when treated with aducanumab. […]
Amgen, Inc . AMGN announced a new analysis from the phase III cardiovascular outcomes study (FOURIER) on its PCSK9 inhibitor, Repatha. This analysis of a large cohort of patients with established atherosclerotic cardiovascular disease showed that there was a strong progressive relationship between lower achieved levels of LDL-C or “bad” cholesterol and a lower risk of cardiovascular events rates. […]
Video game publishing giant, Activision Blizzard Inc. ATVI released the Call of Duty: WWII Private Multiplayer Beta for pre-order customers on Sony’s PlayStation4 (PS4) systems over the last weekend. Reportedly, the second Private Multiplayer Beta weekend will begin on Sep 1 and run through Sep 4 on PS4 as well as Microsoft’s MSFT Xbox One […]
Just when you thought it was safe to focus on other things than North Korea, Kim Jong-un last night launched a missile from Pyongyang over Hokkaido, the main northernmost island of the country of Japan. It’s a clearly provocative move meant to get the attention of President Trump as much as anyone else. Japanese Prime Minister Shinzo Abe wasted no time responding verbally: “This outrageous action of firing a missile over our country is an unprecedented, grave and serious threat that seriously damages peace and security in the region.” Abe also has called for an emergency meeting of the United Nations Security Council, and said he and President Trump spoke about the act for 40 minutes last night, with the president giving a strong commitment to Japan’s security. […]
Tellennium Inc. named to 2017 Inc. 5000 List This marks the eleventh consecutive year for the Louisville area based telecom expense management firm […]
Leading diagnostics testing company, Laboratory Corporation of America Holdings ’ LH agreement with Interpace Diagnostics Group, Inc. (IDXG) has been renewed and extended. Per the extended deal, the agreement will be deemed valid till January 2019, after the successful initial phase […]
The untold damage and misery caused by Hurricane Harvey is not just being felt by the residents of Texas. Markets were also singed by the tropical cyclone on Monday, with energy and financials bearing the brunt of the pain. Stocks of energy companies suffered after key refineries in Texas had to close due to widespread flooding. […]
Sonic Corp. SONC has been recording substandard performance and disappointing investors, of late. In fact, shares of this Zacks Rank #4 (Sell) company have declined more than 17% in the last year, as against the industry ’s gain of 5.3% […]
Abbott Laboratories ABT has made another encouraging move with respect to its Medical Devices business. The company recently announced FDA approval for Full MagLev HeartMate 3 Left Ventricular Assist Device (LVAD). […]
Canadian Pacific Railway Limited CP is currently one of the leading companies of the railroad industry. Shares of the company have rallied 3.6% in the last six months compared with a mere 1% gain of the industry it belongs. Catalysts Behind the Uptick The improvement in the coal scenario is very encouraging for railroads, and Canadian Pacific is no exception. […]
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? […]
Amid a highly challenging retail landscape, Abercrombie & Fitch Co. ANF continues to strengthen its footprint, which in turn, boosts its overall performance in second-quarter fiscal 2017 results. To this end, the company is on track to expand its franchise in the Middle East along with its partner – Majid Al Futtaim […]
In-depth and thorough research are keys to success when it comes to the equity market. Simply following the crowd and investing in risky stocks blindly for lucrative returns will be a wastage of time and money. This is because risky securities derive good returns only when markets are bullish and hence the converse scenario should also be taken into account […]
On Aug 28, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings LH , popularly known as LabCorp. The company is a major player in healthcare diagnostics space, providing comprehensive clinical laboratory services and end-to-end drug development support. Last three months, LabCorp has been trading above the broader industry […]
On Aug 28, we issued an updated research report on fertilizer company, Potash Corp. of Saskatchewan, Inc. […]
Once an industry outperformer, Dick's Sporting Goods Inc. DKS now seems to be in doldrums. This Pennsylvania-based retailer has slumped 22.8% since it reported second-quarter fiscal 2017 results on Aug 15. […]
Anthera Pharmaceuticals, Inc. ANTH announced positive top-line data from the extension of a phase II BRIGHT-SC study, evaluating key pipeline candidate, blisibimod for treatment of patients with IgA nephropathy (IgAN). Notably, the BRIGHT-SC study is randomized, double-blind and placebo-controlled, initiated in June 2013, to evaluate the efficacy, safety, tolerability and immunogenicity of blisibimod in patients with IgAN. […]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes